Differentiated long-term effects of intentional weight loss on diabetes and hypertension

被引:235
作者
Sjöström, CD
Peltonen, M
Wedel, H
Sjöström, L
机构
[1] Univ Gothenburg, Dept Anesthesiol & Intens Care, Gothenburg, Sweden
[2] Univ Gothenburg, Dept Med, Gothenburg, Sweden
[3] Nord Sch Publ Hlth, Gothenburg, Sweden
关键词
obesity; hypertension; essential; diabetes mellitus; weight control; clinical trials;
D O I
10.1161/01.HYP.36.1.20
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The beneficial effects of weight loss in the obese have been widely accepted. Still, there is a lack of controlled studies displaying large maintained weight losses over long periods (>4 years). We wanted to examine the results of long-standing intentional weight loss on the development of diabetes and hypertension in severely obese individuals over an 8-year period. In the ongoing prospective Swedish Obese Subjects (SOS) study, 346 patients awaiting gastric surgery were matched with 346 obese control subjects on 18 variables by a computerized matching program. The controls were drawn from a registry consisting of 1508 obese potential controls examined at primary health care centers in Sweden. Of the 692 selected patients (body mass index 41.2+/-4.7 kg/m(2) [mean+/-SD]), 483 (70%) were followed for 8 years. No significant weight changes occurred in the obese control group over 8 years. Gastric surgery resulted in a maximum weight loss of -31.1+/-13.6 kg after 1 year. After 8 years, the maintained weight loss was still 20.1+/-15.7 kg (16.3+/-12.3%). Whereas this weight reduction had a dramatic effect on the 8-year incidence of diabetes (odds ratio 0.16, 95% CI 0.07 to 0.36), it had no effect on the 8-year incidence of hypertension (odds ratio 1.01, 95% CI 0.61 to 1.67). A differentiated risk factor response was identified: a maintained weight reduction of 16% strongly counteracted the development of diabetes over 8 years but showed no long-term effect on the incidence of hypertension.
引用
收藏
页码:20 / 25
页数:6
相关论文
共 25 条
[1]   RELATION OF WEIGHT CHANGE TO CHANGES IN ATHEROGENIC TRAITS - FRAMINGHAM STUDY [J].
ASHLEY, FW ;
KANNEL, WB .
JOURNAL OF CHRONIC DISEASES, 1974, 27 (03) :103-114
[2]   THE EFFECT OF GASTRIC BYPASS-SURGERY ON HYPERTENSION IN MORBIDLY OBESE PATIENTS [J].
CARSON, JL ;
RUDDY, ME ;
DUFF, AE ;
HOLMES, NJ ;
CODY, RP ;
BROLIN, RE .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (02) :193-200
[3]   Outcomes of pharmacological and surgical treatment for obesity [J].
Cerulli, J ;
Malone, M .
PHARMACOECONOMICS, 1998, 14 (03) :269-283
[4]   REDUCTION IN LONG-TERM ANTIHYPERTENSIVE MEDICATION REQUIREMENTS - EFFECTS OF WEIGHT-REDUCTION BY DIETARY INTERVENTION IN OVERWEIGHT PERSONS WITH MILD HYPERTENSION [J].
DAVIS, BR ;
BLAUFOX, MD ;
OBERMAN, A ;
WASSERTHEILSMOLLER, S ;
ZIMBALDI, N ;
CUTLER, JA ;
KIRCHNER, K ;
LANGFORD, HG .
ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (15) :1773-1782
[5]  
DEITEL M, 1989, SURG MORBIDLY OBESE
[6]  
DORNFELD LP, 1985, INT J OBESITY, V9, P381
[7]   Lowering blood pressure: a systematic review of sustained effects of non-pharmacological interventions [J].
Ebrahim, S ;
Smith, GD .
JOURNAL OF PUBLIC HEALTH MEDICINE, 1998, 20 (04) :441-448
[8]   TEST STATISTIC AND SAMPLE-SIZE FOR A 2-SAMPLE MCNEMAR TEST [J].
FEUER, EJ ;
KESSLER, LG .
BIOMETRICS, 1989, 45 (02) :629-636
[9]   IMPACT OF GASTRIC RESTRICTIVE SURGERY ON HYPERTENSION IN THE MORBIDLY OBESE [J].
FOLEY, EF ;
BENOTTI, PN ;
BORLASE, BC ;
HOLLINGSHEAD, J ;
BLACKBURN, GL .
AMERICAN JOURNAL OF SURGERY, 1992, 163 (03) :294-297
[10]  
GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397